2022-10-04 17:05:04 NVRO Nevro
10/04/22 10/0417:05 10/04/2217:05 | Nevro reports FDA approval of Costa Rica manufacturing operationsNevro announced that the U.S. Food and Drug Administration FDA has approved its manufacturing operations in Costa Rica for the production of its proprietary spinal cord stimulation systems for the treatment of chronic pain, including its HFX product platform. This new facility, located in the Coyol Free Trade Zone in Alajuela, Costa Rica, is Nevro's first global manufacturing operation, ensuring greater controls and efficiency in the manufacture of products to patients around the world and augmenting its already strong manufacturing and supply chain partners. We are pleased that the FDA has approved our new global manufacturing operations in Costa Rica," stated D. Keith Grossman, Chairman, CEO and President of Nevro. "As part of our growth plans moving forward, this manufacturing facility will support our pipeline of future products to ensure that we have the most efficient cost structure and flexible capacity, while maintaining the highest level of quality control as we scale. Thank you to our excellent Costa Rica team for delivering this very meaningful milestone for Nevro." The company anticipates it will begin shipping product by the end of October, with a gradual ramp-up of production for the balance of the year and throughout 2023. Beginning in the second half of 2023 the company expects to see gross margin expansion, increasing over the subsequent three to five years from the high 60s% to the mid-70s%. "This investment will allow us to continue to accomplish our mission to deliver comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment," commented Christofer Christoforou, Vice President of Technical Operations of Nevro. "The capabilities and operations are fully scalable and will allow us to accommodate additional growth and expansion of our product platform." Nevro will have invested approximately $21 million in capital and operating expense by the end of 2022 to support future growth initiatives at this facility to ensure greater controls and efficiency in the manufacture of products to patients around the world. The company currently employs approximately 100 employees at the 41,000-square-foot space. |
|
---|
Recommendations
|
Stryker price target raised to $280 from $250 at Piper Sandler »
21:12 01/31/23 01/3121:12 01/31/2321:12
SYK
Stryker
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Micron exec sells $3.16M in common stock »
20:29 01/31/23 01/3120:29 01/31/2320:29
MU
Micron
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Notable companies reporting before tomorrow's open »
20:25 01/31/23 01/3120:25 01/31/2320:25
TMO
Thermo Fisher
T-Mobile
Altria Group
Boston Scientific
Humana
AmerisourceBergen
Fortive
Dynatrace
Peloton
Brinker
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $5.19... T-Mobile (TMUS), consensus $1.10... Altria (MO), consensus $1.17... Boston Scientific (BSX), consensus 47c... Humana (HUM), consensus $1.46... AmerisourceBergen (ABC), consensus $2.63... Fortive (FTV), consensus 84c... Dynatrace (DT), consensus 21c... Peloton (PTON), consensus (64c)... Brinker (EAT), consensus 52c. ShowHide Related Items >><<
|
Recommendations
|
Oshkosh price target raised to $100 from $93 at Baird »
20:14 01/31/23 01/3120:14 01/31/2320:14
OSK
Oshkosh
Baird analyst Mircea… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 1.1M shares of Invitae today
20:07 01/31/23 01/3120:07 01/31/2320:07
NVTA
Invitae
ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 20.7K shares of Velo3D today
20:07 01/31/23 01/3120:07 01/31/2320:07
VLD
Velo3D
ShowHide Related Items >><<
|
Earnings
|
Waste Management sees FY23 revenue growth of 4.0% to 5.5% »
19:17 01/31/23 01/3119:17 01/31/2319:17
WM
Waste Management
The projected growth rate… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Waste Management reports Q4 EPS $1.30 , consensus $1.41 »
19:13 01/31/23 01/3119:13 01/31/2319:13
WM
Waste Management
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Vorwerk Group SE downgraded to Hold from Buy at Jefferies »
19:11 01/31/23 01/3119:11 01/31/2319:11
FRVWY
Vorwerk Group SE
Jefferies analyst Martin… Story temporarily locked. |
Recommendations
|
Sysco well positioned to drive accelerating growth, says Stephens »
19:02 01/31/23 01/3119:02 01/31/2319:02
SYY
Sysco
Stephens analyst Joshua… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Marin Software announces new integration with Yahoo »
18:58 01/31/23 01/3118:58 01/31/2318:58
MRIN
Marin Software
Marin Software announced… Story temporarily locked. |
Hot Stocks
|
Pfizer CEO: Our best days are still ahead of us »
18:49 01/31/23 01/3118:49 01/31/2318:49
PFE
Pfizer
In an interview on… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Dover price target raised to $165 from $144 at Baird »
18:42 01/31/23 01/3118:42 01/31/2318:42
DOV
Dover
Baird analyst Mircea… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Linamar upgraded to Outperform from Market Perform at BMO Capital »
18:37 01/31/23 01/3118:37 01/31/2318:37
LIMAF
Linamar
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Magna upgraded to Outperform from Market Perform at BMO Capital »
18:37 01/31/23 01/3118:37 01/31/2318:37
MGA
Magna
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Martinrea upgraded to Outperform from Market Perform at BMO Capital »
18:36 01/31/23 01/3118:36 01/31/2318:36
MRETF
Martinrea
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Canadian Tire upgraded to Outperform from Market Perform at BMO Capital »
18:35 01/31/23 01/3118:35 01/31/2318:35
CDNAF
Canadian Tire
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Metro downgraded to Market Perform from Outperform at BMO Capital »
18:34 01/31/23 01/3118:34 01/31/2318:34
MTRAF
Metro
BMO Capital analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
18:32 01/31/23 01/3118:32 01/31/2318:32
CACC
Credit Acceptance
O-I Glass
Stryker
Edwards Lifesciences
AMD
Mondelez
Jasper Therapeutics
Snap
Hawaiian Holdings
Electronic Arts
Match Group
Western Digital
Varex Imaging
Juniper
Super Micro Computer
Ashland
Houlihan Lokey
Taysha Gene Therapies
Poseida Therapeutics
Check out this evening's… ShowHide Related Items >><<
|
Hot Stocks
|
Mesoblast resubmits BLA to FDA for remestemcel-L »
18:31 01/31/23 01/3118:31 01/31/2318:31
MESO
Mesoblast
Mesoblast Limited… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Boston Properties cuts FY23 FFO view to $7.08-$7.18 from $7.15-$7.30
18:28 01/31/23 01/3118:28 01/31/2318:28
BXP
Boston Properties
Consensus $7.18. ShowHide Related Items >><<
|
Hot Stocks
|
Poseida Therapeutics founder and executive chairman Eric Ostertag to retire »
18:28 01/31/23 01/3118:28 01/31/2318:28
PSTX
Poseida Therapeutics
Earlier this evening,… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Boston Properties sees Q1 FFO $1.66-$1.68
18:27 01/31/23 01/3118:27 01/31/2318:27
BXP
Boston Properties
ShowHide Related Items >><<
|
Earnings
|
Boston Properties reports Q4 FFO $1.86, consensus $1.84 »
18:27 01/31/23 01/3118:27 01/31/2318:27
BXP
Boston Properties
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald »
18:26 01/31/23 01/3118:26 01/31/2318:26
BEAM
Beam Therapeutics
Cantor Fitzgerald analyst… Story temporarily locked. ShowHide Related Items >><<
|